Viewing Page 5 of 132 | Showing results 41 - 50 of 1316

Popular weight-loss drugs could harm children

September 12, 2023
IN THE NEWS: Unintended effects of the drugs could affect health across the lifespan, say UCI researchers.

UCI to host CIRM stem cell network symposium

September 01, 2023
The sixth annual Alpha Clinic Network Symposium on Friday, Sept. 8, 2023, will feature presentations by leading stem cell researchers.

GLP-1RA weight-loss drugs may be dangerous to children, UCI researchers warn

UCI Health pediatrician and childhood exercise expert Dr. Dan Cooper  is concerned with the use of GLP-1 medications for children and adolescents.
August 29, 2023
Treating childhood obesity with popular weight-loss drugs may have unintended, adverse health effects, say UCI researchers.

Stem-cell therapy for Parkinson’s disease shows promise in early study

August 29, 2023
IN THE NEWS: A stem-cell-derived therapy for Parkinson’s disease raises new hope after decades of setbacks in the search for an effective...

New RSV monoclonal antibody therapy for infants is significant milestone

August 29, 2023
IN THE NEWS: UCI Health pediatric infectious disease expert discusses infant RSV risks.

UCI awarded grant to study sex-specific brain pathway responses to stress

Dr. Tallie Z. Baram, pictured, led a UC Irvine research team that discovered brain circuitry changes caused by early life adversity that can explain major emotional and mental disorders.
August 28, 2023
Building on the earlier discovery of how brain circuit operation is disrupted by exposure to early-life adversity, researchers will study the...

Alzheimer drug’s approval presents challenges, unknowns

August 25, 2023
IN THE NEWS: The excitement surrounding lecanemab is tempered by concerns about its rigorous regimen.

Castor oil doesn’t belong anywhere near the eyes

August 24, 2023
IN THE NEWS: There is no scientific evidence to support claims on TikTok, says UCI Health expert.

New Alzheimer’s drug benefits a small number of patients

August 23, 2023
IN THE NEWS: Fewer than 20% are eligible for lecanemab, but physicians have discretion with patients in later stages of disease.

Prednisone for rheumatoid arthritis: More research is needed

August 22, 2023
IN THE NEWS: A new study finds no link to hypertension or significant weight gain.